Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | serotonin receptor | 0.0269 | 0.7627 | 0.7627 |
Loa Loa (eye worm) | sema domain-containing protein | 0.0124 | 0.2468 | 0.2468 |
Schistosoma mansoni | hypothetical protein | 0.0124 | 0.2468 | 0.3057 |
Loa Loa (eye worm) | hypothetical protein | 0.0124 | 0.2468 | 0.2468 |
Loa Loa (eye worm) | hypothetical protein | 0.0269 | 0.7627 | 0.7627 |
Schistosoma mansoni | hypothetical protein | 0.0124 | 0.2468 | 0.3057 |
Echinococcus granulosus | semaphorin 5B | 0.0124 | 0.2468 | 0.2468 |
Onchocerca volvulus | 0.0282 | 0.8075 | 1 | |
Schistosoma mansoni | hypothetical protein | 0.0158 | 0.3682 | 0.4559 |
Schistosoma mansoni | semaphorin 5-related | 0.0124 | 0.2468 | 0.3057 |
Loa Loa (eye worm) | sema domain-containing protein | 0.0124 | 0.2468 | 0.2468 |
Brugia malayi | Plexin repeat family protein | 0.0282 | 0.8075 | 0.8075 |
Loa Loa (eye worm) | hypothetical protein | 0.0124 | 0.2468 | 0.2468 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0054 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0158 | 0.3682 | 0.3682 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0054 | 0 | 0.5 |
Brugia malayi | hypothetical protein | 0.0124 | 0.2468 | 0.2468 |
Entamoeba histolytica | tyrosin kinase, putative | 0.0069 | 0.0515 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0054 | 0 | 0.5 |
Schistosoma mansoni | plexin | 0.0282 | 0.8075 | 1 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0054 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0054 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0124 | 0.2468 | 0.2468 |
Brugia malayi | Sema domain containing protein | 0.0124 | 0.2468 | 0.2468 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0054 | 0 | 0.5 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0054 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0054 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0054 | 0 | 0.5 |
Echinococcus granulosus | plexin a4 | 0.0336 | 1 | 1 |
Echinococcus multilocularis | semaphorin 5B | 0.0124 | 0.2468 | 0.2468 |
Echinococcus multilocularis | hypothetical protein | 0.0124 | 0.2468 | 0.2468 |
Loa Loa (eye worm) | plexin A | 0.0336 | 1 | 1 |
Echinococcus granulosus | biogenic amine 5HT receptor | 0.0269 | 0.7627 | 0.7627 |
Loa Loa (eye worm) | hypothetical protein | 0.0124 | 0.2468 | 0.2468 |
Brugia malayi | hypothetical protein | 0.0124 | 0.2468 | 0.2468 |
Loa Loa (eye worm) | hypothetical protein | 0.0282 | 0.8075 | 0.8075 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0054 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0269 | 0.7627 | 0.7627 |
Echinococcus granulosus | semaphorin 1A | 0.0124 | 0.2468 | 0.2468 |
Schistosoma mansoni | plexin | 0.0158 | 0.3682 | 0.4559 |
Loa Loa (eye worm) | hypothetical protein | 0.0124 | 0.2468 | 0.2468 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0069 | 0.0515 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0124 | 0.2468 | 0.2468 |
Brugia malayi | Sema domain containing protein | 0.0124 | 0.2468 | 0.2468 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0269 | 0.7627 | 0.9445 |
Trichomonas vaginalis | Clan MA, family M8, leishmanolysin-like metallopeptidase | 0.0054 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0054 | 0 | 0.5 |
Echinococcus multilocularis | plexin a4 | 0.0336 | 1 | 1 |
Echinococcus multilocularis | serotonin receptor | 0.0269 | 0.7627 | 0.7627 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.